Blood Advances, a Journal of the American Society of Hematology, published online and open access, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology and related sciences. Blood Advances will complement Blood by publishing content not currently covered including case reports, point-counterpoint discussions, and by providing forums to readily comment on published material. The electronic format of Blood Advances provides an opportunity to explore novel approaches for presentation of original content including the use of enhanced graphics, video and online discussion. Additionally, it is hoped that Blood Advances will serve as a hub for dissemination of educational and service needs by providing scholarly content and expert consultation requested by interested parties.

Acceptance of manuscripts is based on the originality or importance of the observations and investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well organized, and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.

Blood Advances has recently added a new scientific category for Health Services and Outcomes submissions. The journal is very interested in submissions as reflected in the definition here.

Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Health Services and Outcomes (new); Hematopoiesis and Stem Cells; Immunobiology; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate.

Authors are invited to contact the Editor-in-Chief prior to submission if they are uncertain whether their work falls within the general scope of the journal. For presubmission inquiries regarding the journal scope, please contact the Blood Advances Editorial Department and include an abstract or detailed summary for consideration.

Volume 5, Issue 1: Pages 1-343 (12 January 2021)

Volume 5, Issue 2: Pages 345-612 (26 January 2021)

Volume 5, Issue 3: Pages 613-925 (9 February 2021)

Volume 5, Issue 4: Pages 927-1136 (23 February 2021)

Volume 5, Issue 5: Pages 1137-1584 (9 March 2021)

Volume 5, Issue 6: Pages 1585-1779 (23 March 2021)

Volume 5, Issue 7: Pages 1781-2053 (13 April 2021)

Volume 5, Issue 8: Pages 2055-2283 (27 April 2021)

Volume 5, Issue 9: Pages 2285-2446 (11 May 2021)

Volume 5, Issue 10: Pages 2447-2504 (25 May 2021)

Volume 5, Issue 11: Pages 2505-2562 (8 June 2021)

Volume 5, Issue 12: Pages 2563-2671 (22 June 2021)

Volume 5, Issue 13: Pages 2673-2798 (13 July 2021)

Volume 5, Issue 14: Pages 2799-2934 (27 July 2021)

Volume 5, Issue 15: Pages 2935-3052 (10 August 2021)

Volume 5, Issue 16: Pages 3053-3239 (24 August 2021)

Volume 5, Issue 17: Pages 3241-3510 (14 September 2021)

Volume 5, Issue 18: Pages 3511-3736 (28 September 2021)

Volume 5, Issue 19: Pages 3737-3912 (12 October 2021)

Volume 5, Issue 20: Pages 3913-4325 (26 October 2021)

Volume 5, Issue 21: Pages 4327-4534 (9 November 2021)

Volume 5, Issue 22: Pages 4535-4805 (23 November 2021)

Volume 5, Issue 23: Pages 4807-5452 (14 December 2021)

Volume 5, Issue 24: Pages 5453-5639 (28 December 2021)